EMAGine’s CXL technology can be found at the CSO Italia booth (G91) and at the Schwind eye-tech solutions booth (E10). Booth booths are located in Hall 8.0.
Pour divers paramètres de kératocônes et de kératites infectieuses.
Profil ajusté selon l'épaisseurProfil de faisceau fournit plus d'énergie dans la périphérie de la cornée.
Batterie de technologie supérieureConstruit pour durer des milliers de traitements.
Accessible aux fauteuils roulantsTraiter commodément les personnes en fauteuil roulant
Convient aux lampes à fente de design Haag Streit et Zeiss.
Lampe à fente ou sur tableFor classic CXL: table mount accessory available.
Protocoles intégrésChoisissez parmi plusieurs protocoles cliniques bien définis.
Gamme d'intensitésDelivers 3, 9, 15, 18 and 30 mW/cm².
L’appareil C-eye est commercialisé avec le marquage CE pour les indications suivantes : kératocône, ectasie après LASIK/PRK, dégénérescence pellucide marginale, kératite infectieuse, fonte stérile de la cornée, kératopathie bulleuse.
Le dispositif C-eye d'EMAGine apporte la technologie du cross-linking à la lampe à fente. Simple, efficace et sûr, du novice à l'expert.
Effectuer le CXL à la lampe à fente ou utilisez notre périphérique C-eye comme n'importe quel autre périphérique de CXL sur une table, dans votre salle d'opération.
Travailler dans des endroits différents? Emportez l'appareil C-eye où que vous soyez. Chargez-le via USB-C, avec le chargeur de votre smartphone ou votre ordinateur portable.
Réduit le temps et les coûts liés à l'exécution du CXL
The C-eye is truly a disruptive and innovative device that opens new avenues in therapeutic refractive surgery, as well as in the treatment of Keratoconus and keratitis. I?m incredibly excited about all these possibilities.
The device is a bliss. I love every aspect of it. Well designed, robust, practical.
Remember that every cross-linking procedure not only improves biomechanics, it also ?disinfects? the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is ?sterile?. And by the way: office-based cataract surgery et office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach ici.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not ?care? whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon?s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see ici.
Find more answers in our FAQ section.
La technologie CXL la plus polyvalente et la plus complète disponible.
The C-eye device fits to a number of Haag-Streit and Zeiss type slit lamps. Find here the complete list of compatible slit lamps
Une riboflavine pour
le kératocône et la kératite
EMAGine’s Medical Director, Prof. Farhad Hafezi, and its CEO, Nikki Hafezi, presented remotely at the CXL Experts’ Summer Meeting 2023,
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News
The advantages of performing corneal cross-linking (CXL) at the slit lamp are well established. It brings CXL out of the
It has been quite the debate. Should surgeons drop riboflavin onto the cornea during the UV irradiation part of a
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
janvier 21, 2022
NUHS 36th Anniversary Conference
Location: Singapore
Language: English
janvier 15, 2022
Muscat International Ophthalmology Conference (MIOC)
Location: Muscat, Oman
Language: English
décembre 4, 2021
Kölner Adventssymposium 2021
Location: Köln, Germany
Language: German
novembre 25, 2021
Middle East Africa Council of Ophthalmology
Location: Dubai, UAE
Language: English
novembre 18, 2021
14th World Down Syndrome Congress
Location: Dubai, UAE
Language: English
novembre 11, 2021
La Société Marocaine de la chirurgie réfractive
Location: Rabat, Morocco
Language: French
novembre 4, 2021
Sorocaba Eye Bank
Location: Brésil
Language: English
octobre 28, 2021
Emirates Society Of Ophthalmology
Location: Dubai, UAE
Language: English
octobre 23, 2021
LV Prasad Eye Institute
Location: Hyderabad, India
Language: English
octobre 23, 2021
65th Brazilian Congress of Ophthalmology
Location: Natal, Brazil
Language: English
